Symbol Technologies, Inc. v. Lemelson Medical, Education & Research Foundation, LP

Case Overview and Background

This declaratory judgment action represents a significant turning point in the long-running and contentious history of patent assertions by one of the 20th century's most prolific and controversial inventors, Jerome H. Lemelson. The plaintiff, Symbol Technologies, Inc., was a leading American manufacturer of barcode scanners and mobile data capture equipment. The defendant was the Lemelson Medical, Education & Research Foundation, LP, a non-practicing entity (NPE) established by Jerome Lemelson to license and enforce his vast patent portfolio, which ultimately collected over $1.5 billion in royalties from hundreds of companies. The dispute centered on threats of infringement litigation by the Lemelson Foundation against customers of Symbol and a co-plaintiff, Cognex Corporation, a manufacturer of machine vision systems. The accused technology broadly covered the use of barcode scanners and machine vision products, which the Foundation alleged were covered by a web of patents stemming from applications filed decades earlier.

At the heart of the case were numerous Lemelson patents, including many asserted to claim priority from applications filed as early as 1954 and 1956. One representative patent is U.S. Patent No. 5,243,655, which generally relates to a "Vision System for an Unmanned and Robot Controlled Vehicle." This and other patents at issue were part of what critics termed a "submarine patent" strategy, where applications were intentionally kept pending in the U.S. Patent and Trademark Office for decades through chains of continuation applications, only to "surface" and be asserted against industries that had independently developed and commercialized the technology. The case was filed in the U.S. District Court for the District of Nevada, a venue where Lemelson had previously faced similar challenges. The action was assigned to Judge Philip M. Pro.

The case is notable for its dramatic outcome and its impact on U.S. patent law. A coalition of technology companies, including Symbol, decided to confront the Lemelson Foundation's licensing campaign head-on rather than pay royalties. Their primary legal theory was that Lemelson's extreme and intentional delays in prosecuting his patents—spanning 18 to 39 years for the asserted claims—constituted "prosecution laches," rendering the patents unenforceable. The District Court agreed, and its decision was ultimately affirmed by the Court of Appeals for the Federal Circuit, establishing a powerful defense against NPEs employing submarine patent strategies. The ruling invalidated a massive patent portfolio, effectively ending what was one of the most lucrative patent licensing campaigns in history and providing a new tool for defendants in patent litigation facing patents with unusually long prosecution histories.

Key Legal Developments and Outcome

This landmark case unfolded over several years, culminating in a definitive appellate ruling that reshaped the landscape for patents procured after exceptionally long delays. The timeline below captures the pivotal moments in the litigation.

Filing and Initial Proceedings

• 1998: The Lemelson Foundation began sending letters to customers of Symbol Technologies, Cognex Corporation, and other manufacturers of barcode scanners and machine vision products, alleging infringement of numerous Lemelson patents.
• 1999-03-26: Symbol Technologies, along with several co-plaintiffs (Accu-Sort Systems, Intermec Technologies, Metrologic Instruments, PSC, Teklogix, and Zebra Technologies), filed a declaratory judgment action in the U.S. District Court for the District of Nevada. They sought a judgment that dozens of Lemelson patents were invalid, unenforceable, and not infringed. The complaint asserted invalidity on multiple grounds (anticipation, obviousness, lack of utility, failure to meet written description and enablement requirements) and unenforceability due to inequitable conduct and, crucially, prosecution laches.
• 1999: Cognex Corporation filed a similar, separate declaratory judgment action, which was later consolidated with the Symbol case before District Judge Philip M. Pro.

Pre-Trial Motions and Interlocutory Appeal

• Motion to Dismiss: The Lemelson Foundation moved to dismiss the actions, arguing there was no actual case or controversy and that the claim of prosecution laches failed to state a claim upon which relief could be granted.
• 2000-03-21: Judge Pro denied the motion to dismiss for lack of controversy but granted the motion to dismiss the prosecution laches claim. The court, following an earlier district court decision in Ford Motor Co. v. Lemelson, held that the equitable doctrine of laches could not be used to override the statutory scheme for continuation applications.
• Interlocutory Appeal to the Federal Circuit (Symbol I): The plaintiffs successfully sought to certify the legal question of prosecution laches for an immediate, interlocutory appeal. The Federal Circuit agreed to hear the appeal on the sole issue of "whether, as a matter of law, the equitable doctrine of laches may be applied to bar enforcement of patent claims that issued after an unreasonable and unexplained delay in prosecution even though the applicant complied with pertinent statutes and rules."
• 2002-01-24: In a watershed decision, the Court of Appeals for the Federal Circuit reversed the district court. In Symbol Technologies, Inc. v. Lemelson Medical, Educ. & Research Found., L.P., 277 F.3d 1361 (Fed. Cir. 2002), the court revived the doctrine of prosecution laches, holding that it was a viable defense. The court reasoned that an "unreasonable and unexplained delay" in prosecution could render a patent unenforceable, and it remanded the case for the district court to determine whether Lemelson's actions met that standard.
• 2002-10: The U.S. Supreme Court denied Lemelson's petition for a writ of certiorari, allowing the Federal Circuit's decision to stand and clearing the way for a trial on the facts.

Trial and District Court Judgment

• Trial: Following remand, the consolidated cases proceeded to a bench trial before Judge Pro.
• 2004-01-23: Judge Pro issued his Findings of Fact and Conclusions of Law, delivering a comprehensive victory for Symbol and Cognex. In his decision, reported at 301 F. Supp. 2d 1147 (D. Nev. 2004), the court found:
  • Prosecution Laches: The asserted claims from fourteen Lemelson patents were unenforceable due to prosecution laches. The court found that Lemelson's delays of 18 to 39 years between the initial patent applications (filed in 1954 and 1956) and the prosecution of the asserted claims were "unreasonable and unjustified." The court noted the significant "intervening private and public rights" that had developed while the applications languished in the PTO.
  • Invalidity: The court also held the asserted claims invalid under 35 U.S.C. § 112 for lack of enablement, finding that a person of ordinary skill in the art could not practice the claimed inventions based on the patent disclosures.
  • Non-Infringement: Adopting the claim construction proposed by the plaintiffs, the court found that the accused products from Symbol and Cognex did not infringe the Lemelson patents.
  • Priority Date: The court determined that Lemelson had failed to prove the asserted patents were entitled to claim priority to the 1954 and 1956 application filing dates.

This ruling was a crushing defeat for the Lemelson Foundation, striking down a patent portfolio that had generated an estimated $1.5 billion in licensing revenue.

Final Appeal and Disposition

• Appeal to the Federal Circuit (Symbol II): The Lemelson Foundation appealed the district court's judgment to the Federal Circuit.
• 2005-09-09: The Federal Circuit affirmed the district court's ruling in Symbol Technologies, Inc. v. Lemelson Medical, Educ. & Research Found., L.P., 422 F.3d 1378 (Fed. Cir. 2005). The appellate court held that the district court did not abuse its discretion in finding the patents unenforceable under prosecution laches. The panel emphasized that while legitimate reasons exist for using continuation applications, "refiling an application solely containing previously-allowed claims for the business purpose of delaying their issuance can be considered an abuse of the patent system." The court went further than the district court and extended the unenforceability ruling to all claims of the asserted patents, not just the 76 claims specifically adjudicated at trial.

The Federal Circuit's 2005 decision marked the definitive end of the litigation and the enforceability of the Lemelson machine vision and barcode patent portfolio. The judgment effectively dismantled one of the most significant and controversial patent licensing campaigns in U.S. history.

Parallel PTAB Proceedings

No parallel Inter Partes Review (IPR) or Post-Grant Review (PGR) proceedings occurred. These AIA trial proceedings were not created until the Leahy-Smith America Invents Act was passed in 2011, long after this case was concluded. The primary challenge to the patents' validity and enforceability occurred entirely within the federal district court and the Federal Circuit.

Counsel for Plaintiff Symbol Technologies, Inc.

Based on court opinions and media reports, the following attorneys and law firms represented plaintiff Symbol Technologies, Inc. in its successful declaratory judgment action against the Lemelson Foundation.

Lead Counsel

• John C. O'Quinn (Lead Counsel)

  • Firm: Kirkland & Ellis LLP (Washington, D.C. office at the time).
  • Note: O'Quinn was a key architect of the successful prosecution laches strategy and argued the case before the Federal Circuit.

• Eugene F. Assaf (Lead Counsel)

  • Firm: Kirkland & Ellis LLP (Washington, D.C. office).
  • Note: Assaf played a significant role in the trial and appellate stages of the case, working alongside John O'Quinn.

• William G. Giltinan

  • Firm: Kirkland & Ellis LLP (Washington, D.C. office at the time).
  • Note: Giltinan was part of the core trial team from Kirkland & Ellis that secured the district court victory.

Local Counsel

• Allan R. Singer (Local Counsel)
  • Firm: Beckley Singleton, Chtd. (Las Vegas, NV at the time; the firm later merged with Lewis Roca Rothgerber).
  • Note: Singer served as the required Nevada-based counsel for the out-of-state Kirkland & Ellis team.

Counsel for Defendant Lemelson Medical, Education & Research Foundation, LP

The Lemelson Foundation was represented by a team of attorneys from several law firms, led by counsel from its primary outside firm based in Chicago.

• Name: Gerald D. Hosier

  • Role: Lead Counsel
  • Firm: Hosier & Sufrin (at the time of the litigation)
  • Note on experience: Hosier was the principal architect of the Lemelson licensing program and its chief enforcement counsel for many years, securing over $1.5 billion in royalties for the foundation. He was known for his aggressive and highly successful patent monetization strategies on behalf of Jerome Lemelson.

• Name: Louis J. Hoffman

  • Role: Counsel
  • Firm: Hosier & Sufrin (at the time of the litigation)
  • Note on experience: Hoffman worked closely with Gerald Hosier on the Lemelson Foundation's nationwide patent licensing and enforcement efforts.

• Name: Steven G. Lisa

  • Role: Counsel
  • Firm: Hosier & Sufrin (at the time of the litigation)
  • Note on experience: Lisa was a key attorney alongside Hosier in managing and litigating the extensive Lemelson patent portfolio.

• Name: Tara C. N. Smith

  • Role: Local Counsel
  • Firm: Morris Law Group, Las Vegas, NV
  • Note on experience: As local counsel in Nevada, Smith assisted the primary litigation team with court appearances and procedural matters in the District of Nevada.

• Name: R. William Reade

  • Role: Counsel
  • Firm: Unknown, based on available records.
  • Note on experience: Reade was involved in representing the Lemelson partnership in this matter, as noted in court opinions.

• Name: Michael R. Friscia

  • Role: Counsel
  • Firm: Friscia & Nussbaum (at the time of appeal)
  • Note on experience: Friscia argued on behalf of the Lemelson Foundation during the appeal at the U.S. Court of Appeals for the Federal Circuit.